Phosphatidylserine-containing liposomes: Potential pharmacological interventions against inflammatory and immune diseases through the production of prostaglandin E2 after uptake by myeloid derived phagocytes

Zhou Wu, Hiroshi Nakanishi

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Phosphatidylserine (PS), which is normally located on the inner leaflet of the plasma membrane, translocates to the outer leaflet at the early stage of apoptosis. The PS externalization provides a signal for phagocytes to initiate uptake of apoptotic cells. After phagocytosis of apoptotic cells, phagocytes induce the secretion of anti-inflammatory mediators including prostaglandin E2 (PGE2). PS-containing liposomes (PSLs) can mimic the effects of apoptotic cells on phagocytes to induce the secretion of PGE 2. PSLs induce the PGE2 secretion from microglia without induction of either cyclooxygenase (COX)-2 or microsomal prostaglandin E synthase (mPGES)-1. PSLs are found to rather utilize COX-1/mPGES-2 system to produce PGE2 secretion and then shift microglia and macrophages from pro- to anti-inflammatory phenotype by an autocrine action of PGE2. Moreover, PSLs inhibit the maturation of dendritic cells and osteoclast precursors. Therefore, PSLs will be potential pharmacological interventions for inflammatory and immune diseases through feedback mechanism utilizing PGE 2.

Original languageEnglish
Pages (from-to)195-201
Number of pages7
JournalArchivum Immunologiae et Therapiae Experimentalis
Volume59
Issue number3
DOIs
Publication statusPublished - Jun 1 2011

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Phosphatidylserine-containing liposomes: Potential pharmacological interventions against inflammatory and immune diseases through the production of prostaglandin E<sub>2</sub> after uptake by myeloid derived phagocytes'. Together they form a unique fingerprint.

  • Cite this